D-20133
D-20133 is an orally active Hexadecylphosphocholine analog. D-20133 can both enhance and inhibit antigen-induced histamine release. D-20133 shows antineoplastic activity against small DMBA (HY-W011845)-induced mammary carcinomas.
For research use only. We do not sell to patients.
- CAS No.: 146764-26-3
- Formula: C26H54NO4P
- Molecular Weight:475.69
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
All Histamine Receptor Isoforms
More
Biological Activity
Chemical Information
-
CAS No. 146764-26-3
-
Molecular Weight 475.69
-
Formula C26H54NO4P
-
SMILES
CCCCCCCCCCCCCCCCCCOP(OCC[N+]1(CCCCC1)C)([O-])=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Grosman N. Effect of the anti-neoplastic agents edelfosine (ET-18-OCH3), ilmofosine (BM 41.440) and the hexadecylphosphocholine analogues D-20133 and D-21266 on histamine release from isolated rat mast cells. Immunopharmacology. 1999 Nov;44(3):211-21. [Content Brief]
[2]. Stekar J, et al. Antineoplastic activity and tolerability of a novel heterocyclic alkylphospholipid, D-20133. Cancer Chemother Pharmacol. 1993;32(6):437-44. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
D-20133 Related Classifications
HY-106919 Related Classifications
Powered by Bioz